ID   MAOX_HUMAN              Reviewed;         572 AA.
AC   P48163; B4DZ70; Q16797; Q16855; Q53F72; Q5VWA2; Q9BWX8; Q9H1W3;
AC   Q9UIY4;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   04-FEB-2015, entry version 149.
DE   RecName: Full=NADP-dependent malic enzyme;
DE            Short=NADP-ME;
DE            EC=1.1.1.40;
DE   AltName: Full=Malic enzyme 1;
GN   Name=ME1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=White adipose tissue;
RX   PubMed=8187880; DOI=10.1016/0014-5793(94)00386-6;
RA   Loeber G., Dworkin M.B., Infante A., Ahorn H.;
RT   "Characterization of cytosolic malic enzyme in human tumor cells.";
RL   FEBS Lett. 344:181-186(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=7622060; DOI=10.1016/0378-1119(95)00004-P;
RA   Gonzalez-Manchon C., Ferrer M., Ayuso M.S., Parrilla R.;
RT   "Cloning, sequencing and functional expression of a cDNA encoding a
RT   NADP-dependent malic enzyme from human liver.";
RL   Gene 159:255-260(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-572 (ISOFORM 1).
RX   PubMed=8804575; DOI=10.1007/BF01887116;
RA   Chou W.Y., Huang S.M., Chang G.G.;
RT   "Nonidentity of the cDNA sequence of human breast cancer cell malic
RT   enzyme to that from the normal human cell.";
RL   J. Protein Chem. 15:273-279(1996).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 15-555.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of a human malic enzyme.";
RL   Submitted (MAR-2007) to the PDB data bank.
CC   -!- CATALYTIC ACTIVITY: (S)-malate + NADP(+) = pyruvate + CO(2) +
CC       NADPH.
CC   -!- CATALYTIC ACTIVITY: Oxaloacetate = pyruvate + CO(2).
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Divalent metal cations. Prefers magnesium or manganese.
CC       {ECO:0000250};
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8187880}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P48163-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48163-2; Sequence=VSP_057051;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested including
CC       liver, placenta and white adipose tissue.
CC       {ECO:0000269|PubMed:7622060, ECO:0000269|PubMed:8187880}.
CC   -!- SIMILARITY: Belongs to the malic enzymes family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=ME1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X77244; CAA54460.1; -; mRNA.
DR   EMBL; L34035; AAB01380.1; -; mRNA.
DR   EMBL; AK302777; BAG63982.1; -; mRNA.
DR   EMBL; AK223417; BAD97137.1; -; mRNA.
DR   EMBL; AL391416; CAH73129.1; -; Genomic_DNA.
DR   EMBL; AL049699; CAH73129.1; JOINED; Genomic_DNA.
DR   EMBL; AL136970; CAH73129.1; JOINED; Genomic_DNA.
DR   EMBL; AL049699; CAI22634.1; -; Genomic_DNA.
DR   EMBL; AL136970; CAI22634.1; JOINED; Genomic_DNA.
DR   EMBL; AL391416; CAI22634.1; JOINED; Genomic_DNA.
DR   EMBL; AL136970; CAC19505.2; -; Genomic_DNA.
DR   EMBL; AL049699; CAC19505.2; JOINED; Genomic_DNA.
DR   EMBL; AL391416; CAC19505.2; JOINED; Genomic_DNA.
DR   EMBL; BC025246; AAH25246.1; -; mRNA.
DR   EMBL; U43944; AAC50613.1; -; mRNA.
DR   CCDS; CCDS34492.1; -. [P48163-1]
DR   PIR; JC4160; JC4160.
DR   PIR; S44415; S44415.
DR   RefSeq; NP_002386.1; NM_002395.5. [P48163-1]
DR   UniGene; Hs.21160; -.
DR   PDB; 2AW5; X-ray; 2.50 A; A/B/C=13-564.
DR   PDB; 3WJA; X-ray; 2.55 A; A/B=1-572.
DR   PDBsum; 2AW5; -.
DR   PDBsum; 3WJA; -.
DR   ProteinModelPortal; P48163; -.
DR   SMR; P48163; 8-570.
DR   BioGrid; 110363; 15.
DR   MINT; MINT-5004289; -.
DR   STRING; 9606.ENSP00000358719; -.
DR   BindingDB; P48163; -.
DR   ChEMBL; CHEMBL3495; -.
DR   PhosphoSite; P48163; -.
DR   DMDM; 1346484; -.
DR   REPRODUCTION-2DPAGE; IPI00008215; -.
DR   MaxQB; P48163; -.
DR   PaxDb; P48163; -.
DR   PeptideAtlas; P48163; -.
DR   PRIDE; P48163; -.
DR   DNASU; 4199; -.
DR   Ensembl; ENST00000369705; ENSP00000358719; ENSG00000065833. [P48163-1]
DR   GeneID; 4199; -.
DR   KEGG; hsa:4199; -.
DR   UCSC; uc003pjy.3; human. [P48163-1]
DR   CTD; 4199; -.
DR   GeneCards; GC06M083920; -.
DR   HGNC; HGNC:6983; ME1.
DR   HPA; HPA006493; -.
DR   MIM; 154250; gene.
DR   neXtProt; NX_P48163; -.
DR   PharmGKB; PA30723; -.
DR   eggNOG; COG0281; -.
DR   GeneTree; ENSGT00390000000754; -.
DR   HOVERGEN; HBG000746; -.
DR   InParanoid; P48163; -.
DR   KO; K00029; -.
DR   OMA; RDVMSKF; -.
DR   OrthoDB; EOG7G4QF0; -.
DR   PhylomeDB; P48163; -.
DR   TreeFam; TF300537; -.
DR   Reactome; REACT_116145; PPARA activates gene expression.
DR   SABIO-RK; P48163; -.
DR   EvolutionaryTrace; P48163; -.
DR   GeneWiki; ME1; -.
DR   GeneWiki; ME1_(gene); -.
DR   GenomeRNAi; 4199; -.
DR   NextBio; 16550; -.
DR   PRO; PR:P48163; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; P48163; -.
DR   CleanEx; HS_ME1; -.
DR   ExpressionAtlas; P48163; baseline and differential.
DR   Genevestigator; P48163; -.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0043531; F:ADP binding; TAS:UniProtKB.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0004471; F:malate dehydrogenase (decarboxylating) (NAD+) activity; IEA:InterPro.
DR   GO; GO:0004473; F:malate dehydrogenase (decarboxylating) (NADP+) activity; IDA:UniProtKB.
DR   GO; GO:0004470; F:malic enzyme activity; IDA:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; TAS:UniProtKB.
DR   GO; GO:0050661; F:NADP binding; TAS:UniProtKB.
DR   GO; GO:0008948; F:oxaloacetate decarboxylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0006108; P:malate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006741; P:NADP biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IEA:Ensembl.
DR   GO; GO:0009743; P:response to carbohydrate; TAS:UniProtKB.
DR   GO; GO:0009725; P:response to hormone; ISS:UniProtKB.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   Gene3D; 3.40.50.10380; -; 1.
DR   Gene3D; 3.40.50.720; -; 1.
DR   InterPro; IPR015884; Malic_enzyme_CS.
DR   InterPro; IPR012301; Malic_N_dom.
DR   InterPro; IPR012302; Malic_NAD-bd.
DR   InterPro; IPR001891; Malic_OxRdtase.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF00390; malic; 1.
DR   Pfam; PF03949; Malic_M; 1.
DR   PIRSF; PIRSF000106; ME; 1.
DR   PRINTS; PR00072; MALOXRDTASE.
DR   SMART; SM00919; Malic_M; 1.
DR   PROSITE; PS00331; MALIC_ENZYMES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Metal-binding; NADP; Oxidoreductase; Reference proteome.
FT   CHAIN         1    572       NADP-dependent malic enzyme.
FT                                /FTId=PRO_0000160192.
FT   NP_BIND     301    318       NADP. {ECO:0000250}.
FT   ACT_SITE    102    102       Proton donor. {ECO:0000250}.
FT   ACT_SITE    173    173       Proton acceptor. {ECO:0000250}.
FT   METAL       245    245       Divalent metal cation. {ECO:0000250}.
FT   METAL       246    246       Divalent metal cation. {ECO:0000250}.
FT   METAL       269    269       Divalent metal cation. {ECO:0000250}.
FT   BINDING     155    155       NADP. {ECO:0000250}.
FT   BINDING     269    269       NADP. {ECO:0000250}.
FT   BINDING     408    408       NADP. {ECO:0000250}.
FT   SITE        269    269       Important for activity. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:19413330}.
FT   VAR_SEQ       1     75       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057051.
FT   CONFLICT    266    266       F -> S (in Ref. 4; BAD97137).
FT                                {ECO:0000305}.
FT   CONFLICT    438    438       P -> S (in Ref. 7; AAC50613).
FT                                {ECO:0000305}.
FT   CONFLICT    443    448       NGQTLY -> DGRTLF (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    472    477       QITDNI -> HIDDKV (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    486    486       A -> S (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    495    495       E -> Q (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    515    515       E -> V (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    519    519       K -> Q (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    523    523       Q -> K (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    526    526       T -> M (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    538    538       A -> E (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    541    541       R -> S (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    548    548       D -> N (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    558    558       S -> P (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    561    561       E -> A (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   CONFLICT    571    571       D -> N (in Ref. 2; AAB01380).
FT                                {ECO:0000305}.
FT   HELIX        16     20       {ECO:0000244|PDB:2AW5}.
FT   TURN         22     24       {ECO:0000244|PDB:2AW5}.
FT   HELIX        27     29       {ECO:0000244|PDB:2AW5}.
FT   HELIX        32     37       {ECO:0000244|PDB:2AW5}.
FT   TURN         41     43       {ECO:0000244|PDB:2AW5}.
FT   HELIX        51     64       {ECO:0000244|PDB:2AW5}.
FT   HELIX        68     81       {ECO:0000244|PDB:2AW5}.
FT   HELIX        83     91       {ECO:0000244|PDB:2AW5}.
FT   TURN         95     97       {ECO:0000244|PDB:2AW5}.
FT   HELIX        98    101       {ECO:0000244|PDB:2AW5}.
FT   HELIX       105    111       {ECO:0000244|PDB:2AW5}.
FT   HELIX       113    116       {ECO:0000244|PDB:2AW5}.
FT   STRAND      122    126       {ECO:0000244|PDB:2AW5}.
FT   HELIX       127    129       {ECO:0000244|PDB:2AW5}.
FT   HELIX       133    137       {ECO:0000244|PDB:2AW5}.
FT   STRAND      147    151       {ECO:0000244|PDB:2AW5}.
FT   TURN        157    159       {ECO:0000244|PDB:2AW5}.
FT   HELIX       163    167       {ECO:0000244|PDB:2AW5}.
FT   HELIX       168    181       {ECO:0000244|PDB:2AW5}.
FT   HELIX       185    187       {ECO:0000244|PDB:2AW5}.
FT   STRAND      188    194       {ECO:0000244|PDB:2AW5}.
FT   HELIX       200    204       {ECO:0000244|PDB:2AW5}.
FT   HELIX       218    236       {ECO:0000244|PDB:2AW5}.
FT   STRAND      241    244       {ECO:0000244|PDB:2AW5}.
FT   HELIX       249    259       {ECO:0000244|PDB:2AW5}.
FT   TURN        260    262       {ECO:0000244|PDB:2AW5}.
FT   STRAND      263    267       {ECO:0000244|PDB:2AW5}.
FT   TURN        268    270       {ECO:0000244|PDB:2AW5}.
FT   HELIX       271    288       {ECO:0000244|PDB:2AW5}.
FT   HELIX       292    294       {ECO:0000244|PDB:2AW5}.
FT   STRAND      297    301       {ECO:0000244|PDB:2AW5}.
FT   HELIX       304    320       {ECO:0000244|PDB:2AW5}.
FT   HELIX       324    328       {ECO:0000244|PDB:2AW5}.
FT   STRAND      331    335       {ECO:0000244|PDB:2AW5}.
FT   HELIX       351    354       {ECO:0000244|PDB:2AW5}.
FT   HELIX       364    371       {ECO:0000244|PDB:2AW5}.
FT   STRAND      374    378       {ECO:0000244|PDB:2AW5}.
FT   HELIX       388    397       {ECO:0000244|PDB:2AW5}.
FT   STRAND      402    405       {ECO:0000244|PDB:2AW5}.
FT   HELIX       410    412       {ECO:0000244|PDB:2AW5}.
FT   HELIX       417    423       {ECO:0000244|PDB:2AW5}.
FT   TURN        424    426       {ECO:0000244|PDB:2AW5}.
FT   STRAND      429    434       {ECO:0000244|PDB:2AW5}.
FT   HELIX       454    456       {ECO:0000244|PDB:2AW5}.
FT   HELIX       458    468       {ECO:0000244|PDB:2AW5}.
FT   HELIX       475    487       {ECO:0000244|PDB:2AW5}.
FT   HELIX       491    495       {ECO:0000244|PDB:2AW5}.
FT   HELIX       503    505       {ECO:0000244|PDB:2AW5}.
FT   HELIX       506    523       {ECO:0000244|PDB:2AW5}.
FT   HELIX       536    542       {ECO:0000244|PDB:2AW5}.
FT   HELIX       561    564       {ECO:0000244|PDB:3WJA}.
SQ   SEQUENCE   572 AA;  64150 MW;  EA4C8CB36F6C619C CRC64;
     MEPEAPRRRH THQRGYLLTR NPHLNKDLAF TLEERQQLNI HGLLPPSFNS QEIQVLRVVK
     NFEHLNSDFD RYLLLMDLQD RNEKLFYRVL TSDIEKFMPI VYTPTVGLAC QQYSLVFRKP
     RGLFITIHDR GHIASVLNAW PEDVIKAIVV TDGERILGLG DLGCNGMGIP VGKLALYTAC
     GGMNPQECLP VILDVGTENE ELLKDPLYIG LRQRRVRGSE YDDFLDEFME AVSSKYGMNC
     LIQFEDFANV NAFRLLNKYR NQYCTFNDDI QGTASVAVAG LLAALRITKN KLSDQTILFQ
     GAGEAALGIA HLIVMALEKE GLPKEKAIKK IWLVDSKGLI VKGRASLTQE KEKFAHEHEE
     MKNLEAIVQE IKPTALIGVA AIGGAFSEQI LKDMAAFNER PIIFALSNPT SKAECSAEQC
     YKITKGRAIF ASGSPFDPVT LPNGQTLYPG QGNNSYVFPG VALGVVACGL RQITDNIFLT
     TAEVIAQQVS DKHLEEGRLY PPLNTIRDVS LKIAEKIVKD AYQEKTATVY PEPQNKEAFV
     RSQMYSTDYD QILPDCYSWP EEVQKIQTKV DQ
//
